COVID-19 infection prevention and control management during
hyperbaric oxygen therapy: a best practice implementation
project

J 2023

COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project

HAJEK, Michal, Dittmar CHMELAR, Miroslav ROZLOZNIK, Alexandra LOCHMANOVA, Jakub TLAPAK et. al.

Basic information

Original name

COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project

Authors

HAJEK, Michal (203 Czech Republic), Dittmar CHMELAR (203 Czech Republic), Miroslav ROZLOZNIK (203 Czech Republic), Alexandra LOCHMANOVA (203 Czech Republic), Jakub TLAPAK (203 Czech Republic), Tereza VRBOVÁ (203 Czech Republic, belonging to the institution), Miloslav KLUGAR (203 Czech Republic, belonging to the institution) and Jitka KLUGAROVÁ (203 Czech Republic, belonging to the institution)

Edition

JBI EVIDENCE IMPLEMENTATION, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2691-3321

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 2.300 in 2022

RIV identification code

RIV/00216224:14110/23:00133702

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1097/XEB.0000000000000400

UT WoS

001111566500002

Keywords in English

COVID-19; health care professionals; hyperbaric oxygen therapy; infection control

Abstract

V originále

Objective:This implementation project compared standard operating procedures, accepted preventive measures, and disinfection procedures between the initial stage of the COVID-19 pandemic (first wave: March 15 to May 31, 2020) and the later stages of the pandemic (second and third waves: September 1, 2020 to January 31, 2021).Introduction:This project sought to improve compliance with international evidence-based guidelines and clinical standards for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy taking into account the conditions of the local hospital.Methods:Guided by the JBI evidence implementation framework, seven evidence-based audit criteria were developed for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy. A questionnaire was used to measure compliance in baseline and follow-up audits.Results:Differences between the baseline and follow-up audits were noted for criteria 6 and 7. Criterion 6 increased from 0% to 100% as the hyperbaric facility was equipped with certified ultraviolet-C radiation for air disinfection during the later period, but this equipment was not available in the initial period of the pandemic. Criterion 7 dropped from 100% in the baseline audit to 0% in the follow-up audit because of a significant increase in the operational burden of the treatment capacity of the facility, which made it impossible to comply with the recommended distancing between patients.Conclusions:Differences were found in preventive measures, disinfection procedures, work organization, and approach to care strategy. The project objectives were met and the implementation strategies proved effective. Larger sample sizes would need be needed to confirm the reproducibility of the results.

Citovat

HAJEK, Michal, Dittmar CHMELAR, Miroslav ROZLOZNIK, Alexandra LOCHMANOVA, Jakub TLAPAK, Tereza VRBOVÁ, Miloslav KLUGAR and Jitka KLUGAROVÁ. COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project. JBI EVIDENCE IMPLEMENTATION. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 21, S1, p. "S57"-"S63", 7 pp. ISSN 2691-3321. Available from: https://dx.doi.org/10.1097/XEB.0000000000000400.

@article{2379981,
   author = {Hajek, Michal and Chmelar, Dittmar and Rozloznik, Miroslav and Lochmanova, Alexandra and Tlapak, Jakub and Vrbová, Tereza and Klugar, Miloslav and Klugarová, Jitka},
   article_location = {PHILADELPHIA},
   article_number = {S1},
   doi = {http://dx.doi.org/10.1097/XEB.0000000000000400},
   keywords = {COVID-19; health care professionals; hyperbaric oxygen therapy; infection control},
   language = {eng},
   issn = {2691-3321},
   journal = {JBI EVIDENCE IMPLEMENTATION},
   title = {COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project},
   url = {https://journals.lww.com/ijebh/fulltext/2023/12001/covid_19_infection_prevention_and_control.7.aspx},
   volume = {21},
   year = {2023}
}

TY  - JOUR
ID  - 2379981
AU  - Hajek, Michal - Chmelar, Dittmar - Rozloznik, Miroslav - Lochmanova, Alexandra - Tlapak, Jakub - Vrbová, Tereza - Klugar, Miloslav - Klugarová, Jitka
PY  - 2023
TI  - COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project
JF  - JBI EVIDENCE IMPLEMENTATION
VL  - 21
IS  - S1
SP  - "S57"-"S63"
EP  - "S57"-"S63"
PB  - LIPPINCOTT WILLIAMS & WILKINS
SN  - 26913321
KW  - COVID-19
KW  - health care professionals
KW  - hyperbaric oxygen therapy
KW  - infection control
UR  - https://journals.lww.com/ijebh/fulltext/2023/12001/covid_19_infection_prevention_and_control.7.aspx
N2  - Objective:This implementation project compared standard operating procedures, accepted preventive measures, and disinfection procedures between the initial stage of the COVID-19 pandemic (first wave: March 15 to May 31, 2020) and the later stages of the pandemic (second and third waves: September 1, 2020 to January 31, 2021).Introduction:This project sought to improve compliance with international evidence-based guidelines and clinical standards for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy taking into account the conditions of the local hospital.Methods:Guided by the JBI evidence implementation framework, seven evidence-based audit criteria were developed for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy. A questionnaire was used to measure compliance in baseline and follow-up audits.Results:Differences between the baseline and follow-up audits were noted for criteria 6 and 7. Criterion 6 increased from 0% to 100% as the hyperbaric facility was equipped with certified ultraviolet-C radiation for air disinfection during the later period, but this equipment was not available in the initial period of the pandemic. Criterion 7 dropped from 100% in the baseline audit to 0% in the follow-up audit because of a significant increase in the operational burden of the treatment capacity of the facility, which made it impossible to comply with the recommended distancing between patients.Conclusions:Differences were found in preventive measures, disinfection procedures, work organization, and approach to care strategy. The project objectives were met and the implementation strategies proved effective. Larger sample sizes would need be needed to confirm the reproducibility of the results.
ER  -

HAJEK, Michal, Dittmar CHMELAR, Miroslav ROZLOZNIK, Alexandra LOCHMANOVA, Jakub TLAPAK, Tereza VRBOVÁ, Miloslav KLUGAR and Jitka KLUGAROVÁ. COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project. \textit{JBI EVIDENCE IMPLEMENTATION}. PHILADELPHIA: LIPPINCOTT WILLIAMS \&{} WILKINS, 2023, vol.~21, S1, p.~''S57''-''S63'', 7 pp. ISSN~2691-3321. Available from: https://dx.doi.org/10.1097/XEB.0000000000000400.

Detailed Information on Publication Record